A detailed history of Adar1 Capital Management, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 1,571,705 shares of RZLT stock, worth $7.58 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
1,571,705
Previous 2,063,962 23.85%
Holding current value
$7.58 Million
Previous $8.88 Billion 14.11%
% of portfolio
1.24%
Previous 1.68%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.13 - $5.31 $2.03 Million - $2.61 Million
-492,257 Reduced 23.85%
1,571,705 $7.62 Billion
Q2 2024

Aug 13, 2024

BUY
$2.29 - $5.79 $4.73 Million - $12 Million
2,063,962 New
2,063,962 $8.88 Billion

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $187M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.